Publishing research using ab28842? Please let us know so that we can cite the reference in this datasheet.

ab28842 has been referenced in 6 publications.

  • Chayka O  et al. Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells. J Biol Chem 290:2198-212 (2015). WB ; Human . PubMed: 25477524
  • Xiao L  et al. Targeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy. Oncogene N/A:N/A (2014). Human . PubMed: 24662831
  • Izumi H & Kaneko Y Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells. Cancer Res 74:5620-30 (2014). PubMed: 25100564
  • Dong LH  et al. Histone deacetylase inhibitor potentiated the ability of MTOR inhibitor to induce autophagic cell death in Burkitt leukemia/lymphoma. J Hematol Oncol 6:53 (2013). WB . PubMed: 23866964
  • Grim JE  et al. Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer. Mol Cell Biol 32:2160-7 (2012). PubMed: 22473991
  • Heine VM  et al. Dexamethasone destabilizes Nmyc to inhibit the growth of hedgehog-associated medulloblastoma. Cancer Res 70:5220-5 (2010). WB ; Mouse . PubMed: 20530674

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"